Morningstar® Stock Report™

Novo Nordisk A/S NVO

Gewinnmarge (% des Umsatzes)
20192020202120222023
Ertrag100,00%100,00%100,00%100,00%100,00%
Betriebskosten16,46%16,49%16,80%16,08%15,40%
Bruttogewinn83,54%83,51%83,20%83,92%84,60%
Vertriebsgemeinkosten29,36%29,06%29,16%28,64%26,52%
Forschung und Entwicklung11,65%12,18%12,62%13,59%13,97%
Umsatzrendite43,01%42,64%41,65%42,28%44,16%
Net Int, Inc and Other82,80%84,49%83,61%81,30%89,23%
EBIT Marge39,79%41,85%41,96%39,03%45,07%
Ertragskraft
20192020202120222023
Steuersatz7,87%8,66%8,04%7,65%9,04%
Nettomarge31,92%33,19%33,92%31,38%36,03%
Gesamtkapitalrendite32,9631,1528,1425,4830,12
Financial Leverage2,182,292,752,892,95
Eigenkapitalsrendite71,1969,7071,2472,0088,07